Trademarkia Logo

Australia

AU$
Trademark Search
QUVIVIQ

View On IPO.GOV.AU

QUVIVIQ
Cancelled: Cancelled at the request of IB

Last updated on 13 Feb 2023

Owner Info

Idorsia Pharmaceuticals Ltd

Hegenheimermattweg 91

CH-4123 Allschwil, SWITZERLAND

Serial Number

2302317 filed on 6 Jul 2022

Correspondent

Keller Schneider Patent- und Markenanwälte AG

Beethovenstrasse 49,

Postfach,

SWITZERLAND

QUVIVIQ

Classification Information

Class [005]
Pharmaceutical preparations intended for the prevention or treatment of cardiovascular diseases, hypertension, cerebral haemorrhages and sequela there Read More

Mark Details

Serial Number

2302317

Registered On

6 Jul 2022

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)

Date

7 Jan 2022

Mark Type

CH

Legal History

Show more

Status DateAction Taken
13th Feb 2023Status change to Voided
9th Feb 2023International Registration - Correction Received
7th Dec 2022International Registration in Australia Protected correspondence sent
6th Dec 2022IP Right Registration Published
6th Dec 2022Status change to Registered/Protected
30th Sept 2022Application Accepted correspondence sent
29th Sept 2022IP Right has been Examined
29th Sept 2022IP Right Acceptance Published
29th Sept 2022Status change to Accepted
29th Sept 2022Awaiting examination